glycidamide has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ardanaz, E; Baglietto, L; Boeing, H; Boutron-Ruault, MC; Bueno-de-Mesquita, HB; Castaño, JM; Chamosa, S; Duell, EJ; Ferrari, P; Fortner, RT; Freisling, H; Gunter, MJ; Idahl, A; Khaw, KT; Klinaki, E; Lujan-Barroso, L; Lundin, E; Mattiello, A; Menéndez, V; Merritt, MA; Obón-Santacana, M; Onland-Moret, NC; Ose, J; Papatesta, EM; Peeters, PH; Riboli, E; Sacerdote, C; Saieva, C; Sánchez-Cantalejo, E; Severi, G; Tagliabue, G; Travis, RC; Trichopoulou, A; Tumino, R; Vesper, HW; Wareham, N; Weiderpass, E | 1 |
1 other study(ies) available for glycidamide and Invasiveness, Neoplasm
Article | Year |
---|---|
Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.
Topics: Acrylamide; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Biomarkers; Case-Control Studies; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Epoxy Compounds; Female; Follow-Up Studies; Hemoglobins; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nutrition Assessment; Ovarian Neoplasms; Postmenopause; Prognosis; Prospective Studies; Risk Factors | 2016 |